On May 13, 2013, a Notice to the Bar was issued by Judge Glenn A. Grant, Acting Administrator of the Courts, advising that an application had been made, pursuant to Directive #7-09, “Revised Mass Tort Guidelines,” requesting designation of all New Jersey state-court litigation involving Mirena Intrauterine device (IUD) as a multicounty litigation and assignment for centralized management in Bergen County.  The federal cases have already been consolidated in the in the Southern District of New York. All New Jersey cases shall be assigned for to Judge Brian R. Martinotti in Bergen County, New Jersey, who will be overseeing all aspects of pretrial discovery.

As we have previously reported, women across the country have alleged serious injuries resulting from their use of Mirena IUD.  These complications include device expulsion, device dislocation, perforation and vaginal hemorrhage that may require hospitalization or surgery.

If you feel you have experienced any side-effects from using the Mirena IUD, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against Bayer.

The Mirena Intrauterine device (IUD) is a hormonal device that is inserted into a woman’s uterus for long-term birth control. A T-shaped plastic frame releases a type of progestin that prevents sperm from reaching or fertilizing an egg. Originally, the device was marketed to prevent pregnancy for up to five years after insertion. However, women across the country have experienced serious injuries from the use of Mirena IUD.  These complications include device expulsion, device dislocation and vaginal hemorrhage that may require hospitalization or surgery. Some studies estimate that close to 50,000 adverse incidents have been reported to the FDA from Mirena alone.

The Hon. Cathy Seibel, U.S.D.J., presides over the federal multi-district litigation (MDL 2434) in the Southern District of New York addressing claims against the manufacturers and/or distributors of Mirena.  Judge Seibel held a case management conference on May 17, 2013, wherein the parties discussed various scheduling and discovery issues. Following the conference, Judge Seibel also entered an Order selecting Plaintiffs’ Liaison and Co-Lead Counsel, who will assist in streamlining the federal litigation. By June 17, 2013, plaintiffs’ counsel must submit their proposals for the appointment of Plaintiffs’ Steering Committee.

If you feel you have experienced any side-effects from using the Mirena IUD, you can contact Stark & Stark and speak to one of the Mass Tort/Pharmaceutical Litigation attorneys, free of charge, who can help assess any claims that you might have against Bayer.